In this plenary session, Alexandra M. Oster, from the CDC, discusses molecular detection of HIV clusters, how the United States has used that data, and how researchers have responded to these clusters. ...
For his Bernard Fields Lecture at CROI 2019, Dr Michel C. Nussenzweig from the Rockefeller University in New York discussed the discovery and development of HIV broadly neutralizing antibodies.
For his Bernard Fields Lecture at CROI 2019, Dr Michel C. Nussenzweig from the Rockefeller University in New York discussed the discovery and development of HIV broadly neutralizing antibodies.
While weight gain occurs after ART initiation with all modern regimens, researchers of a study presented at CROI 2019 determined whether INSTI-based ART is associated with excess weight gain.
While weight gain occurs after ART initiation with all modern regimens, researchers of a study presented at CROI 2019 determined whether INSTI-based ART is associated with excess weight gain.
In Thursday’s Plenary Session at CROI 2019, David Blast, from the University of Liverpool highlighted the drug interactions in the older HIV population, the need for more searchable databases, and which...
In Thursday’s Plenary Session at CROI 2019, David Blast, from the University of Liverpool highlighted the drug interactions in the older HIV population, the need for more searchable databases, and which...
Several biomarkers obtained through non-invasive means could help to predict the development of non-alcoholic fatty liver disease in patients living with HIV (PWH), according to recent research.
The FibroScan-AST (FAST) score has been shown to be effective for the risk assessment of non-alcoholic hepatic steatosis (NASH) in patients without HIV, but its effectiveness in HIV+ patients is currently...
